Natural killer cell cytotoxicity in elderly humans after influenza immunization

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 1, 1996, Pages 105-108

  Kutza, Joseph ^a   Gross, Peter ^b   Kaye, Donald ^a   Murasko, Donna M ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; INFLUENZA VACCINE;

AGED; ARTICLE; CLINICAL TRIAL; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; INFLUENZA; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030071804     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.1.105-108.1996     Document Type: Article

References (20)

1. Albright, J. W., and J. F. Albright. 1989. Natural killer cell mediated resistance to parasites. In C. W. Reynolds and A. H. Witrout (ed.). Functions of the natural immune system. Plenum Press, New York.
2. Arora, D. J. S., and D. M. Justewicz. 1988. Human influenza viral neuraminidases augment cell mediated cytotoxicity in vitro. Nat. Immun. Cell Growth Regul 7:87-94.
3. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpes virus infection in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735.
4. Biron, C. A., and R. M. Welsh. 1982. Blastogenesis of natural killer cells during viral infection in vivo. J. Immunol. 129:2788-2795.
5. Brunner, K. J., J. Mauel, J. C. Cerottini, and B. Chapuis. 1968. Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogenic target cells in vitro: inhibition by isoantibody and by drugs. Immunology 14:181-196.
6. Bukowski, J. F., B. A. Woda, S. Habu, K. Okamura, and R. M. Welsh. 1983. Natural killer cell depletion enhances virus synthesis and virus induced hepatitis in vivo. J. Immunol. 131:1531-1538.
7. Ennis, F. A., A. S. Beare, D. Riley, G. Schild, A. Meager, R. Yi Hua, C. Schwarz, and A. I. I. Rook. 1981. Interferon induction and increased natural killer activity in influenza infections in man. Lancet ii:891-893.
8. Fitzgerald, R. A., R. Evans, D. Kirkpatrick, and C. Lopez. 1983. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1 infected fibroblasts and K562 erythroleukemic targets. J. Immunol. 130:1633-1637.
9. Garcia-Penarrubia, P., F. T. Koster, R. O. Kelley, T. D. McDowell, and A. D. Bankhurst. 1989. Antibacterial activity of human natural killer cells. J. Exp. Med. 169:99-113.
10. Gross, P. A., M. E. Weksler, G. V. Quinnan, Jr., R. G. Douglas, Jr., P. F. Gaerlan, and C. R. Denning. 1987. Immunization of elderly people with two doses of influenza vaccine. J. Clin. Microbiol. 25:1763-1765.
11. Guffee, J., W. Fan, and J. Stein-Streilein. 1989. The role of natural killer cells in early defense to influenza virus infection by the intranasal route, p. 124. In E. W. Ades and C. Lopez (ed.), Natural killer cells and host defense. S. Karger, Basel.
12. Herberman, R. B., and J. R. Ortaldo. 1981. Natural killer cells: their role in defense against disease. Science 214:24-30.
13. Herrman, F., R. E. Schmidt, J. Ritz, and J. D. Griffin. 1987. In vitro regulation of human hematopoiesis by natural killer cells: analysis at a clonal level. Blood 69:246-254.
14. Kendal, A. P., and W. R. Dowdle. 1986. Influenza virus, p. 515-520. In N. R. Rose, H. Friedman, and J. L. Fahey (ed.), Manual of clinical laboratory immunology, 3rd ed. American Society for Microbiology, Washington, D.C.
15. Kohl, S., L. S. Loo, F. S. Schmalstieg, and D. C. Anderson. 1986. The genetic deficiency of leukocyte surface glycoprotein MAC-1, LFA-1, p150/95 in humans is associated with defective antibody-dependent cellular cytotoxicity in vitro and defective protection against herpes simplex virus infections in vivo. J. Immunol. 137:1688-1694.
16. Krishnaraj, R., and G. Blandford. 1987. Age associated alterations in human natural killer cells. 1. Increased activity as per conventional and kinetic analysis. Clin. Immunol. Immunopathol. 45:268-285.
17. Kutza, J., D. Kaye, and D. M. Murasko. 1995. Basal natural killer cell activity of elderly humans: a review. J. Gerontol. 50:8110-116.
18. Kutza, J., and D. M. Murasko. 1994. Effects of aging on natural killer cell activity and activation by interleukin-2 and interferon-alpha. Cell. Immunol. 155:195-204.
19. Lozzio, C. B., and B. B. Lozzio. 1975. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45:321-334.
20. Murphy, J. W. 1989. Natural host resistance mechanisms against systemic mycotic agents. In C. W. Reynolds and A. H. Witrout (ed.), Functions of the natural immune system. Plenum Press, New York.